Structural analysis of light chain-driven bispecific antibodies targeting CD47 and PD-L1

In contrast to natural antibodies that rely mainly on the heavy chain to establish contacts with their cognate antigen, we have developed a bispecific antibody format in which the light chain (LC) drives antigen binding and specificity. To better understand epitope-paratope interactions in this cont...

Full description

Saved in:
Bibliographic Details
Main Authors: Pauline Malinge, Xavier Chauchet, Jérémie Bourguignon, Nicolas Bosson, Sébastien Calloud, Tereza Bautzova, Marie Borlet, Mette Laursen, Vinardas Kelpsas, Nadia Rose, Franck Gueneau, Ulla Ravn, Giovanni Magistrelli, Nicolas Fischer
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:mAbs
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/19420862.2024.2362432
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832576545005240320
author Pauline Malinge
Xavier Chauchet
Jérémie Bourguignon
Nicolas Bosson
Sébastien Calloud
Tereza Bautzova
Marie Borlet
Mette Laursen
Vinardas Kelpsas
Nadia Rose
Franck Gueneau
Ulla Ravn
Giovanni Magistrelli
Nicolas Fischer
author_facet Pauline Malinge
Xavier Chauchet
Jérémie Bourguignon
Nicolas Bosson
Sébastien Calloud
Tereza Bautzova
Marie Borlet
Mette Laursen
Vinardas Kelpsas
Nadia Rose
Franck Gueneau
Ulla Ravn
Giovanni Magistrelli
Nicolas Fischer
author_sort Pauline Malinge
collection DOAJ
description In contrast to natural antibodies that rely mainly on the heavy chain to establish contacts with their cognate antigen, we have developed a bispecific antibody format in which the light chain (LC) drives antigen binding and specificity. To better understand epitope-paratope interactions in this context, we determined the X-ray crystallographic structures of an antigen binding fragment (Fab) in complex with human CD47 and another Fab in complex with human PD-L1. These Fabs contain a κ-LC and a λ-LC, respectively, which are paired with an identical heavy chain (HC). The structural analysis of these complexes revealed the dominant contribution of the LCs to antigen binding, but also that the common HC provides some contacts in both CD47 and PD-L1 Fab complexes. The anti-CD47 Fab was affinity optimized by diversifying complementary-determining regions of the LC followed by phage display selections. Using homology modeling, the contributions of the amino acid modification to the affinity increase were analyzed. Our results demonstrate that, despite a less prominent role in natural antibodies, the LC can mediate high affinity binding to different antigens and neutralize their biological function. Importantly, Fabs containing a common variable heavy (VH) domain enable the generation of bispecific antibodies retaining a truly native structure, maximizing their therapeutic potential.
format Article
id doaj-art-5417c41908304d66b55eaa0280c419ce
institution Kabale University
issn 1942-0862
1942-0870
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series mAbs
spelling doaj-art-5417c41908304d66b55eaa0280c419ce2025-01-31T04:19:38ZengTaylor & Francis GroupmAbs1942-08621942-08702024-12-0116110.1080/19420862.2024.2362432Structural analysis of light chain-driven bispecific antibodies targeting CD47 and PD-L1Pauline Malinge0Xavier Chauchet1Jérémie Bourguignon2Nicolas Bosson3Sébastien Calloud4Tereza Bautzova5Marie Borlet6Mette Laursen7Vinardas Kelpsas8Nadia Rose9Franck Gueneau10Ulla Ravn11Giovanni Magistrelli12Nicolas Fischer13Light Chain Bioscience - Novimmune SA, Plan-les-Ouates, SwitzerlandLight Chain Bioscience - Novimmune SA, Plan-les-Ouates, SwitzerlandLight Chain Bioscience - Novimmune SA, Plan-les-Ouates, SwitzerlandLight Chain Bioscience - Novimmune SA, Plan-les-Ouates, SwitzerlandLight Chain Bioscience - Novimmune SA, Plan-les-Ouates, SwitzerlandLight Chain Bioscience - Novimmune SA, Plan-les-Ouates, SwitzerlandLight Chain Bioscience - Novimmune SA, Plan-les-Ouates, SwitzerlandSARomics Biostructures AB, Lund, SwedenSARomics Biostructures AB, Lund, SwedenSARomics Biostructures AB, Lund, SwedenLight Chain Bioscience - Novimmune SA, Plan-les-Ouates, SwitzerlandLight Chain Bioscience - Novimmune SA, Plan-les-Ouates, SwitzerlandLight Chain Bioscience - Novimmune SA, Plan-les-Ouates, SwitzerlandLight Chain Bioscience - Novimmune SA, Plan-les-Ouates, SwitzerlandIn contrast to natural antibodies that rely mainly on the heavy chain to establish contacts with their cognate antigen, we have developed a bispecific antibody format in which the light chain (LC) drives antigen binding and specificity. To better understand epitope-paratope interactions in this context, we determined the X-ray crystallographic structures of an antigen binding fragment (Fab) in complex with human CD47 and another Fab in complex with human PD-L1. These Fabs contain a κ-LC and a λ-LC, respectively, which are paired with an identical heavy chain (HC). The structural analysis of these complexes revealed the dominant contribution of the LCs to antigen binding, but also that the common HC provides some contacts in both CD47 and PD-L1 Fab complexes. The anti-CD47 Fab was affinity optimized by diversifying complementary-determining regions of the LC followed by phage display selections. Using homology modeling, the contributions of the amino acid modification to the affinity increase were analyzed. Our results demonstrate that, despite a less prominent role in natural antibodies, the LC can mediate high affinity binding to different antigens and neutralize their biological function. Importantly, Fabs containing a common variable heavy (VH) domain enable the generation of bispecific antibodies retaining a truly native structure, maximizing their therapeutic potential.https://www.tandfonline.com/doi/10.1080/19420862.2024.2362432Bispecificlight chainCD47PD-L1structureX-ray crystallography
spellingShingle Pauline Malinge
Xavier Chauchet
Jérémie Bourguignon
Nicolas Bosson
Sébastien Calloud
Tereza Bautzova
Marie Borlet
Mette Laursen
Vinardas Kelpsas
Nadia Rose
Franck Gueneau
Ulla Ravn
Giovanni Magistrelli
Nicolas Fischer
Structural analysis of light chain-driven bispecific antibodies targeting CD47 and PD-L1
mAbs
Bispecific
light chain
CD47
PD-L1
structure
X-ray crystallography
title Structural analysis of light chain-driven bispecific antibodies targeting CD47 and PD-L1
title_full Structural analysis of light chain-driven bispecific antibodies targeting CD47 and PD-L1
title_fullStr Structural analysis of light chain-driven bispecific antibodies targeting CD47 and PD-L1
title_full_unstemmed Structural analysis of light chain-driven bispecific antibodies targeting CD47 and PD-L1
title_short Structural analysis of light chain-driven bispecific antibodies targeting CD47 and PD-L1
title_sort structural analysis of light chain driven bispecific antibodies targeting cd47 and pd l1
topic Bispecific
light chain
CD47
PD-L1
structure
X-ray crystallography
url https://www.tandfonline.com/doi/10.1080/19420862.2024.2362432
work_keys_str_mv AT paulinemalinge structuralanalysisoflightchaindrivenbispecificantibodiestargetingcd47andpdl1
AT xavierchauchet structuralanalysisoflightchaindrivenbispecificantibodiestargetingcd47andpdl1
AT jeremiebourguignon structuralanalysisoflightchaindrivenbispecificantibodiestargetingcd47andpdl1
AT nicolasbosson structuralanalysisoflightchaindrivenbispecificantibodiestargetingcd47andpdl1
AT sebastiencalloud structuralanalysisoflightchaindrivenbispecificantibodiestargetingcd47andpdl1
AT terezabautzova structuralanalysisoflightchaindrivenbispecificantibodiestargetingcd47andpdl1
AT marieborlet structuralanalysisoflightchaindrivenbispecificantibodiestargetingcd47andpdl1
AT mettelaursen structuralanalysisoflightchaindrivenbispecificantibodiestargetingcd47andpdl1
AT vinardaskelpsas structuralanalysisoflightchaindrivenbispecificantibodiestargetingcd47andpdl1
AT nadiarose structuralanalysisoflightchaindrivenbispecificantibodiestargetingcd47andpdl1
AT franckgueneau structuralanalysisoflightchaindrivenbispecificantibodiestargetingcd47andpdl1
AT ullaravn structuralanalysisoflightchaindrivenbispecificantibodiestargetingcd47andpdl1
AT giovannimagistrelli structuralanalysisoflightchaindrivenbispecificantibodiestargetingcd47andpdl1
AT nicolasfischer structuralanalysisoflightchaindrivenbispecificantibodiestargetingcd47andpdl1